Completed
Led by National Institute of Allergy and Infectious Diseases (NIAID) · Updated on 2021-11-03
850
Participants Needed
19
Research Sites
N/A
Total Duration
This study is designed to find out whether HIV-positive patients whose immune systems have improved after receiving anti-HIV treatment should take azithromycin to prevent Mycobacterium avium complex (MAC) disease. This study also examines the possibility of putting off MAC prevention treatment in patients who respond well to anti-HIV drug therapy. Azithromycin is approved for the prevention of MAC disease in people with HIV and low CD4 cell counts. However, some people who have taken azithromycin have been found to carry antibiotic-resistant bacteria (germs that can grow despite the presence of drugs used to kill them). It is not known whether the risks associated with taking azithromycin outweigh the risk of getting MAC disease.
CONDITIONS
A Study to Evaluate the Effects of Azithromycin on MAC Disease Prevention in HIV-Positive Patients
You may qualify if you...
Inclusion Criteria
You may be eligible for this study if you:
Exclusion Criteria
You will not be eligible for this study if you:
You will not qualify if you...
History of severe allergic reactions to study medication Currently pregnant or breastfeeding Recent participation in another clinical trial within the last 30 days Presence of uncontrolled medical conditions that could affect safety
Total: 19 locations
1
Community Consortium / Jon Kaiser Wellness Ctr
San Francisco, California, United States, 94110
Status Unknown
2
Community Consortium / UCSF
San Francisco, California, United States, 94110
Status Unknown
3
Denver CPCRA / Denver Public Hlth
Denver, Colorado, United States, 80204
Status Unknown
4
Washington Reg AIDS Prog / Dept of Infect Dis
Washington D.C., District of Columbia, United States, 20422
Status Unknown
5
AIDS Research Consortium of Atlanta
Atlanta, Georgia, United States, 30308
Status Unknown
6
AIDS Research Alliance - Chicago
Chicago, Illinois, United States, 60657
Status Unknown
7
Louisiana Comm AIDS Rsch Prog / Tulane Univ Med
New Orleans, Louisiana, United States, 70112
Status Unknown
8
LSMUC / Lions Clinic
New Orleans, Louisiana, United States, 70112
Status Unknown
9
Catherine McAuley Health Ctr
Detroit, Michigan, United States, 48201
Status Unknown
10
Wayne State Univ - WSU/DMC / Univ Hlth Ctr
Detroit, Michigan, United States, 48201
Status Unknown
11
Henry Ford Hosp
Detroit, Michigan, United States, 48202
Status Unknown
12
Southern New Jersey AIDS Cln Trials / Dept of Med
Camden, New Jersey, United States, 08103
Status Unknown
13
North Jersey Community Research Initiative
Newark, New Jersey, United States, 07103
Status Unknown
14
Partners in Research / New Mexico
Albuquerque, New Mexico, United States, 87131
Status Unknown
15
Harlem AIDS Treatment Grp / Harlem Hosp Ctr
New York, New York, United States, 10037
Status Unknown
16
The Research and Education Group
Portland, Oregon, United States, 97210
Status Unknown
17
Philadelphia FIGHT
Philadelphia, Pennsylvania, United States, 19107
Status Unknown
18
Saint Joseph's Hosp
Philadelphia, Pennsylvania, United States, 19107
Status Unknown
19
Richmond AIDS Consortium / Div of Infect Diseases
Richmond, Virginia, United States, 23298
Status Unknown
Study Type
INTERVENTIONAL
Masking
N/A
Allocation
N/A
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
0
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
W M El-Sadr, W J Burman, L B Grant...
https://pubmed.ncbi.nlm.nih.gov/10766581